ReviewPharmacoEconomics2004
Drotrecogin alfa (activated): a pharmacoeconomic review of its use in severe sepsis.
James E Frampton et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewPharmacoEconomics2004
James E Frampton et al.PubMed ↗Publisher ↗
No numbers read from the abstract.